Home
Parenteral Drugs (india) Ltd Share Price History
Parenteral Drugs (India) Ltd
NSE : 21 Aug, 2023
2.90.1 (1.8%)
Prev Close
2.8
Open Price
2.7
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
867
Today's High / Low
2.9 / 2.7
52 WK High / Low
2.9 / 0.0
Market Price of Parenteral Drugs (India) Ltd
1M
1Y
3Y
5Y
Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -118 |
| BVPS | -108.42 |
Key Financial Parameters
| Parameter | 2012 |
|---|---|
| Return on Capital Emp. % | -0.01 |
| Op. Profit Mgn % | 4.22 |
| Net Profit Mgn % | -15.69 |
| Debt to Equity % | 1.04 |
Latest Shareholding
Promoters Holdings Over Time
About Parenteral Drugs (India) Ltd
- Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company.
- In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum.
- In March 1994, the company was converted into a public limited company. Parenteral Drugs (India) is an India-based pharmaceutical company.
- The Company manufactures, and markets pharmaceutical products in India, including solid and liquid orals, such as antibiotics and anti-bacterial, anti-ulcerant, analgesics/anti-inflammatory, multivitamins and minerals, anxiolyic , antiprotozoal, anticold, anthelmintic, anti-histaminic, muscle relaxant, cardiac, antidiabetic, cough syrup, appetite enhancer and injections. The Company produces various therapeutic segments of In-Vitro (I V) Fluids, such as electrolytes, antibacterial, energy replenisher, irrigation solution, osmotic diuretic, dialysis solution.
Popular Search
FAQs for Parenteral Drugs (India) Ltd Share Price History
What are the key events that typically impact Parenteral Drugs (India) Ltd's share price history?
Key events that impact Parenteral Drugs (India) Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Parenteral Drugs (India) Ltd's share price history?
Stock splits reduce the nominal price of Parenteral Drugs (India) Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Parenteral Drugs (India) Ltd?
Dividends can influence Parenteral Drugs (India) Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Parenteral Drugs (India) Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Parenteral Drugs (India) Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Parenteral Drugs (India) Ltd’s share price history?
To understand Parenteral Drugs (India) Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
